Skip to main navigation Skip to search Skip to main content

Outcomes of anti-PD1 antibodies for advanced melanoma in real-world population

  • M. C.T. van Zeijl
  • , M. W.J.M. Wouters
  • , A. J. van den Eertwegh
  • , M. J. Aarts
  • , A. C.J. van Akkooi
  • , F. W.P.J. van den Berkmortel
  • , M. G. Franken
  • , J. W.B. de Groot
  • , K. H. Herbschleb
  • , J. J.M. van der Hoeven
  • , G. A.P. Hospers
  • , E. Kapiteijn
  • , D. Piersma
  • , R. S. van Rijn
  • , K. P.M. Suijkerbuijk
  • , A. J. Ten Tije
  • , A. A.M. Van der Veldt
  • , G. Vreugdenhil
  • , J. B.A.G. Haanen
  • Leiden University
  • Antoni van Leeuwenhoek Hospital
  • Maastricht University
  • Zuyderland Hospital
  • Erasmus University Rotterdam
  • Isala Clinics
  • Radboud University Nijmegen
  • University of Groningen
  • Medisch Spectrum Twente
  • Medical Centre Leeuwarden
  • Utrecht University
  • Amphia Hospital
  • Maxima Medical Centre

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)viii455
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Volume29
DOIs
Publication statusPublished - 1 Oct 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this